Good Shepherd Medication Management (EIN 463313048) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2014

Legal Domicile

Principal Officer

Dr Philip J Baker

Phone

9019213039

Tax Period

2024-01-01 to 2024-12-31

Good Shepherd Medication Management, founded in 2014, is a mid-sized nonprofit in the Unknown sector that reported $23.0M in total revenue in fiscal year 2024. Revenue surged 2723% from the prior year, signaling strong growth momentum. The organization ran a surplus of $22.4M, a strong 97% operating margin.

Mission

Good Shepherd Medication Management exists to glorify God by improving the lives of our members through affordable pharmacy services for the uninsured.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $22,799,819

Program Service Revenue $218,780

Investment Income $0

Other Revenue $0

TOTAL REVENUE $23,018,599

Expense Breakdown

Grants Paid $208,037

Salaries & Benefits $69,973

Fundraising Expenses $63,572

Program Expenses $454,883

Other Expenses $308,608

TOTAL EXPENSES $586,618

Year-over-Year Comparison

	2024	2023	Change
Revenue	$23,018,599	$815,374	+27.2%
Expenses	$586,618	$1,265,218	-0.5%
Net Income	$22,431,981	$-449,844	-50.9%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$65,000

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Dr Philip J Baker	CEO	15.00	Officer	$65,000	$0	$65,000
Chris Moore	Trustee	1.00	Director	$0	$0	$0
Liz Robinson	Trustee	40.00	Director	$0	$0	$0
Sachie Stover	Secretary	40.00	Director	$0	$0	$0
Michelle Zulu	Treasurer	40.00	Director	$0	$0	$0
Ayile Arnett	Chairman	1.00	Director	$0	$0	$0
Carmon Heilman	Trustee	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$23,018,599	$586,618	$22,897,448	$22,431,981
2023	$815,374	$1,265,218	$345,120	$-449,844
2022	$2,347,722	$3,175,618	$810,516	$-827,896
2021	$1,862,836	$2,607,270	$1,363,068	$-744,434
2020	$2,559,042	$4,738,043	$2,325,879	$-2,179,001
2019	$4,967,043	$4,244,057	$4,508,291	$722,986
2018	$6,166,210	$6,155,036	$120,595	$11,174

Good Shepherd Medication Management